Home
PhoenixBio

PhoenixBio Market Share Analysis for June 2026

フェニックスバイオは、ヒト肝細胞キメラマウスであるPXBマウスを利用した医薬品開発の受託試験サービスを提供しています。PXBマウスは世界で最も利用されているヒト肝細胞キメラマウスです。

Health > Biotechnology and Pharmaceuticals

Domainphoenixbio.co.jp

Year Founded2002

Employees51 - 200

Annual Revenue$10M - $15M

PhoenixBio

PhoenixBio (including company regionals)

phoenixbio.co.jp

See more website traffic and engagement information

PhoenixBio Revenue up to June 2026 is 10M - 15M

revenue generated by PhoenixBio top domains

PhoenixBio top domains revenue over 3 years

Revenue for PhoenixBio top domains

phoenixbio.co.jp10M - 15M

See more with Sales Intelligence

Total visits to PhoenixBio's top domains

Understand PhoenixBio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

phoenixbio.co.jp2.7K

See more with Sales Intelligence

Avg. visit duration in PhoenixBio's top domains

Analyze PhoenixBio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

phoenixbio.co.jp00:02:57

See more with Sales Intelligence

Avg. pageviews on PhoenixBio's top domains

See how PhoenixBio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

phoenixbio.co.jp2.88

See more with Sales Intelligence

PhoenixBio top competitors by domain

Top similar sites in June 2026, ranked by their affinity

kmbiologics.comCompany NameKM BiologicsEmployees1001 - 5000HQJapan, kita-kuAnnual revenue--Total visits9.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by PhoenixBio

These are the website technologies, by industry, used by PhoenixBio top domains

Widget (4)

Twemoji

Advertising (3)

Google Adsense

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from PhoenixBio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInotiv Inc. partners with PhoenixBio Co., Ltd..Inotiv ( NOTV +0.6% ) has collaborated with Japan-based PhoenixBio Co. to provide research services in Inotiv’s U.S. labs using PhoenixBio’s proprietary PXB-mouse research model, a liver-humanized chimeric model used for drug discovery and early development.

NewsKMT Hepatech, Inc. merged with PhoenixBio Co., Ltd. on Jan 1st '17.In 2017, seeking to capitalize on growing business opportunities and to maximize international reach, KMT Hepatech merged with PhoenixBio Group, an international conglomerate headquartered in Hiroshima, Japan.

NewsPhoenixBio Co., Ltd. promotes Takashi Shimada to President & CEO.AND PHOENIXBIO USA CORPORATION – HIROSHIMA, JAPAN, JUNE 29TH, 2018 Promotion of New President & CEO of PhoenixBio Co., Ltd. and PhoenixBio USA Corporation – Hiroshima, Japan, June 29th, 2018 Mr. Takashi Shimada has been promoted to President & CEO of PhoenixBio Co., Ltd. (Hiroshima, Japan) effective on June 28th, 2018.